Market Cap : 67.21 B | Enterprise Value : 61.16 B | PE Ratio : 5.23 | PB Ratio : 3.75 |
---|
NAS:MRNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:MRNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Moderna has the GF Value Rank of 2.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Biotechnology subindustry, Moderna's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Moderna's GF Value Rank distribution charts can be found below:
* The bar in red indicates where Moderna's GF Value Rank falls into.
Thank you for viewing the detailed overview of Moderna's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Gomez Jorge M | officer: See Remarks | C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Burton Paul | officer: Chief Medical Officer | 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 |
Klinger Shannon Thyme | officer: Chief Legal Officer | 200 TECHNOLOGY SQUARE SUITE 300 CAMBRIDGE MA 02139 |
Le Goff Corinne | officer: Chief Commercial Officer | 200 TECHNOLOGY SQUARE SUITE 300 CAMBRIDGE MA 02139 |
Tallett Elizabeth E | director | 6705 ROCKLEDGE DR SUITE 900 BETHESDA MD 20817 |
Meline David W | officer: Chief Financial Officer | 3M COMPANY 3M OFFICE OF GENERAL COUNSEL ST PAUL MN 55144-1000 |
Horning Sandra | director | 333 LAKESIDE DRIVE FOSTER CITY CA 94404 |
Nader Francois | director | 550 HILLS DRIVE BEDMINSTER NJ 07921 |
Flagship Venturelabs Iv, Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02143 |
Sagan Paul | director | AKAMAI TECHNOLOGIES INC 8 CAMBRIDGE CENTER CAMBRIDGE MA 02142 |
Ruiz Israel | director | C/O FORTIVE CORPORATION 6920 SEAWAY BOULEVARD EVERETT WA 98203 |
Zaks Tal Zvi | officer: Chief Medical Officer | C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX |
Nabel Elizabeth G | director | BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON MA 02115 |
Hoge Stephen | officer: President | C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 |
Henderson Lori M. | officer: General Counsel and Secretary | MOLDFLOW CORP 430 BOSTON POST ROAD WAYLAND MA 01778 |
From GuruFocus
By ACCESSWIRE 04-04-2022
Other Sources
By Zacks 2022-04-06
By Fool 2022-03-30
By Zacks 2022-04-05
By Zacks 2022-03-24
By Zacks 2022-04-01
By Zacks 2022-03-23
By Zacks 2022-03-22
By Zacks 2022-03-30
By Zacks 2022-03-21
By Fool 2022-03-29
By tipranks.com 2022-03-25
By Fool 2022-04-05
By Fool 2022-03-24
By Zacks 2022-03-22
By Zacks 2022-03-21